Marksans Pharma

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue188.46157.35214.66220.60242.69
Expenses153.96134.51160.27176.10208.09
EBITDA39.5327.0159.3853.2343.30
EBIT35.3523.5154.6644.7334.87
Profit Before Tax34.5022.8554.3944.5034.60
Net Profit25.6217.8144.1931.2925.29
Financial Ratios
Operating Profit Margin22.88%17.65%32.62%26.01%17.94%
Net Profit Margin14.83%11.64%24.27%15.29%10.48%
Earning Per Share (Diluted)0.630.430.980.690.56
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.8
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ